Short description: Squam cell ca skin NOS. ICD-9-CM 173.92 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 173.92 should only be used for claims with a date of service on or before September 30, 2015.
2015/16 ICD-10-CM C44.82 Squamous cell carcinoma of overlapping sites of skin. ICD-9-CM codes are used in medical billing and coding to describe diseases, injuries, symptoms and conditions. ICD-9-CM 173.82 is one of thousands of ICD-9-CM codes used in healthcare.
2015 ICD-9-CM Diagnosis Code 199.1. Other malignant neoplasm without specification of site. ICD-9-CM 199.1 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 199.1 should only be used for claims with a date of service on or before September 30, 2015.
ICD-9-CM 199.1 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 199.1 should only be used for claims with a date of service on or before September 30, 2015. For claims with a date of service on or after October 1, 2015, use an equivalent ICD-10-CM code (or codes).
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Morphology [Histology] Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, ...
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Morphology [Histology] Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, ...
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Morphology [Histology] Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, ...
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Morphology [Histology] Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, ...
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Morphology [Histology] Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, ...
A type 1 excludes note is a pure excludes. It means "not coded here". A type 1 excludes note indicates that the code excluded should never be used at the same time as C79.9. A type 1 excludes note is for used for when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
This is a shortened version of the second chapter of the ICD-9: Neoplasms. It covers ICD codes 140 to 239. The full chapter can be found on pages 101 to 144 of Volume 1, which contains all (sub)categories of the ICD-9. Volume 2 is an alphabetical index of Volume 1. Both volumes can be downloaded for free from the website of the World Health Organization.
See here for a tabular overview of primary, secondary, in situ, and benign neoplasms.
• 140 Malignant neoplasm of lip
• 141 Malignant neoplasm of tongue
• 142 Malignant neoplasm of major salivary glands
• 143 Malignant neoplasm of gum
• 150 Malignant neoplasm of esophagus
• 151 Malignant neoplasm of stomach
• 152 Malignant neoplasm of small intestine, including duodenum
• 153 Malignant neoplasm colon
• 160 Malignant neoplasm of nasal cavities, middle ear, and accessory sinuses
• 161 Malignant neoplasm of larynx
• 162 Malignant neoplasm of trachea, bronchus, and lung
• 163 Malignant neoplasm of pleura
• 170 Malignant neoplasm of bone and articular cartilage
• 171 Malignant neoplasm of connective and other soft tissue
• 172 Malignant melanoma of skin
• 173 Other malignant neoplasm of skin
• 176 Kaposi's sarcoma
• 176 Kaposi's sarcoma
• 179 Malignant neoplasm of uterus, part unspecified
• 180 Malignant neoplasm of cervix uteri
• 181 Malignant neoplasm of placenta
• 182 Malignant neoplasm of body of uterus
• 179 Malignant neoplasm of uterus, part unspecified
• 180 Malignant neoplasm of cervix uteri
• 181 Malignant neoplasm of placenta
• 182 Malignant neoplasm of body of uterus
• 190 Malignant neoplasm of eye
• 191 Malignant neoplasm of brain
• 192 Malignant neoplasm of other and unspecified parts of nervous system
• 193 Malignant neoplasm of thyroid gland